Company / Working Capital
Quest Diagnostics Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$100.0M
FY2025
5-year range
$100.0M / $988.0M
FY2021-FY2025
Trend
-55.2%
vs FY2024
Sector context
#131 of 160
Health Care
What the data says
Quest Diagnostics's working capital of $100M is lower than 82% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from -$95M in FY2018 to $1.3B in FY2020.
Based on SEC 10-K filings.
$100M in FY2025 with a 5-year CAGR of -40.0%.
Declined from $557M to $100M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -33.9%
- 5-Year CAGR
- -40.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 160This company $100.0M Sector average $757.1M
▼
-86.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -40.0%, indicating a declining trend.
- In FY2025, working capital decreased 55.2% year-over-year.
- Ranks #131 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $100.0M | -55.2% |
| FY2024 | $223.0M | -60.0% |
| FY2023 | $557.0M | +60.5% |
| FY2022 | $347.0M | -64.9% |
| FY2021 | $988.0M | -22.9% |
| FY2020 | $1.3B | +156.4% |
| FY2019 | $500.0M | +626.3% |
| FY2018 | -$95.0M | -138.2% |
| FY2017 | $249.0M | -54.7% |
| FY2016 | $550.0M | +67.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026